Coiro, Stefano
Huttin, Olivier
Kobayashi, Masatake
Lamiral, Zohra
Simonovic, Dejan
Zannad, Faiez
Rossignol, Patrick
Girerd, Nicolas http://orcid.org/0000-0002-3278-2057
Article History
Accepted: 20 July 2022
First Online: 30 August 2022
Declarations
:
: Under French law, the analysis of mono-centre hospital data does not require written informed consent or ethical committee approval. The study on the ambulatory HFpEF cohort of the Cardiology Clinic of the Niska Banja was approved by the local ethics committee and managed in accordance with Good Clinical Practice and the Declaration of Helsinki. All patients provided written informed consent.
: Pr Girerd. reports personal fees from AstraZeneca, Bayer, Boehringer, Lilly, Novartis, and Vifor, outside the submitted work. Pr Rossignol reports (outside this manuscript) consulting for Bayer, CinCor, G3P, Idorsia, and KBP; honoraria from Ablative Solutions, AstraZeneca, Bayer, Boehringer-Ingelheim, Corvidia, CVRx, Fresenius, Grunenthal, Novartis, Novo Nordisk, Roche, Relypsa Inc., a Vifor Pharma Group Company, Sanofi, Sequana Medical, Servier, Stealth Peptides, and Vifor Fresenius Medical Care Renal Pharma; Cofounder: CardioRenal. All of the other authors have nothing to declare.